JIC
NVO

Johnson Investment Counsel’s Novo Nordisk NVO Stock Holding History

Johnson Investment Counsel’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$674K Sell
14,055
-246
-2% -$10.6K ﹤0.01% 540
2026
Q1 		$526K Sell
14,301
-1,891
-12% -$89.6K ﹤0.01% 572
2025
Q4 		$824K Sell
16,192
-550
-3% -$28.1K 0.01% 443
2025
Q3 		$929K Sell
16,742
-3,637
-18% -$213K 0.01% 445
2025
Q2 		$1.41M Buy
20,379
+4,511
+28% +$307K 0.01% 359
2025
Q1 		$1.1M Sell
15,868
-1,739
-10% -$144K 0.01% 390
2024
Q4 		$1.51M Buy
17,607
+1,617
+10% +$175K 0.01% 332
2024
Q3 		$1.9M Sell
15,990
-2,738
-15% -$365K 0.02% 296
2024
Q2 		$2.67M Buy
18,728
+365
+2% +$48.4K 0.03% 223
2024
Q1 		$2.36M Sell
18,363
-2,739
-13% -$326K 0.03% 242
2023
Q4 		$2.18M Buy
21,102
+1,126
+6% +$111K 0.03% 242
2023
Q3 		$1.82M Sell
19,976
-100
-0.5% -$8.81K 0.02% 257
2023
Q2 		$1.62M Sell
20,076
-2,558
-11% -$209K 0.02% 280
2023
Q1 		$1.8M Sell
22,634
-180
-0.8% -$12.8K 0.02% 262
2022
Q4 		$1.54M Sell
22,814
-4,112
-15% -$241K 0.02% 281
2022
Q3 		$1.34M Buy
26,926
+322
+1% +$17.3K 0.02% 278
2022
Q2 		$1.48M Sell
26,604
-596
-2% -$33.1K 0.02% 272
2022
Q1 		$1.52M Buy
27,200
+36
+0.1% +$1.85K 0.02% 280
2021
Q4 		$1.52M Sell
27,164
-944
-3% -$51.1K 0.02% 282
2021
Q3 		$1.35M Buy
28,108
+6,188
+28% +$299K 0.02% 292
2021
Q2 		$918K Sell
21,920
-336
-2% -$13K 0.01% 345
2021
Q1 		$761K Sell
22,256
-200
-0.9% -$7.12K 0.01% 359
2020
Q4 		$784K Buy
22,456
+200
+0.9% +$6.91K 0.01% 344
2020
Q3 		$773K Hold
22,256
– – 0.01% 324
2020
Q2 		$729K Sell
22,256
-2,800
-11% -$89.4K 0.01% 330
2020
Q1 		$765K Sell
25,056
-2,230
-8% -$66.4K 0.02% 297
2019
Q4 		$790K Hold
27,286
– – 0.01% 355
2019
Q3 		$705K Sell
27,286
-2,528
-8% -$63.9K 0.01% 361
2019
Q2 		$760K Buy
29,814
+4,230
+17% +$105K 0.02% 352
2019
Q1 		$669K Sell
25,584
-1,830
-7% -$45K 0.01% 365
2018
Q4 		$631K Hold
27,414
– – 0.02% 363
2018
Q3 		$646K Sell
27,414
-144
-0.5% -$3.51K 0.01% 399
2018
Q2 		$635K Buy
27,558
+2,660
+11% +$63.2K 0.02% 390
2018
Q1 		$613K Sell
24,898
-540
-2% -$14.2K 0.02% 379
2017
Q4 		$682K Buy
25,438
+224
+0.9% +$5.7K 0.02% 361
2017
Q3 		$607K Sell
25,214
-2,184
-8% -$49.4K 0.02% 363
2017
Q2 		$587K Buy
27,398
+3,122
+13% +$63K 0.02% 371
2017
Q1 		$416K Sell
24,276
-1,744
-7% -$30.4K 0.01% 434
2016
Q4 		$466K Buy
26,020
+3,108
+14% +$56.3K 0.01% 389
2016
Q3 		$476K Sell
22,912
-900
-4% -$22.3K 0.02% 356
2016
Q2 		$640K Buy
23,812
+900
+4% +$24.7K 0.02% 290
2016
Q1 		$620K Sell
22,912
-72
-0.3% -$1.93K 0.02% 287
2015
Q4 		$667K Sell
22,984
-2,758
-11% -$76.3K 0.02% 272
2015
Q3 		$698K Buy
25,742
+2,966
+13% +$84K 0.03% 259
2015
Q2 		$623K Sell
22,776
-2,000
-8% -$56.2K 0.02% 278
2015
Q1 		$661K Buy
24,776
+490
+2% +$11.3K 0.02% 272
2014
Q4 		$513K Buy
24,286
+486
+2% +$10.9K 0.02% 312
2014
Q3 		$566K Hold
23,800
– – 0.02% 295
2014
Q2 		$549K Buy
23,800
+2,010
+9% +$44.4K 0.02% 269
2014
Q1 		$497K Sell
21,790
-4,700
-18% -$100K 0.02% 281
2013
Q4 		$489K Buy
26,490
+400
+2% +$6.97K 0.02% 284
2013
Q3 		$441K Hold
26,090
– – 0.02% 282
2013
Q2 		$404K Buy
+26,090
New +$434K 0.02% 287

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Johnson Investment Counsel's NVO Position: Q2 2026 in Review

Johnson Investment Counsel reduced its Novo Nordisk (NVO) stake by 1.7% in Q2 2026, selling an estimated $10.6K and leaving 14,055 shares worth $674K. The position accounts for ﹤0.01% of the portfolio, ranked #540.

Johnson Investment Counsel first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.67M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Johnson Investment Counsel held 14,055 shares of Novo Nordisk worth $674K as of Q2 2026.
  • Johnson Investment Counsel sold 246 Novo Nordisk shares in Q2 2026, an estimated $10.6K.
  • Novo Nordisk made up ﹤0.01% of Johnson Investment Counsel's portfolio in Q2 2026, its #540 holding.
  • Johnson Investment Counsel first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
  • Johnson Investment Counsel's Novo Nordisk position peaked at $2.67M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.